Editorial: Novel Molecular Targets and Treatments for Gastroesophageal Cancer.
作者信息
Lam Alfred King-Yin, Li Bin, Liang Linhui, Xie Jianjun, Xu Wen Wen
机构信息
School of Medicine & Dentistry and Menzies Health Institute Queensland, Griffith University, Gold Coast, QSL, Australia.
The Fifth Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.
出版信息
Front Oncol. 2022 May 13;12:888861. doi: 10.3389/fonc.2022.888861. eCollection 2022.
Abstract
摘要
相似文献
1
Editorial: Novel Molecular Targets and Treatments for Gastroesophageal Cancer.
Front Oncol. 2022 May 13;12:888861. doi: 10.3389/fonc.2022.888861. eCollection 2022.
2
Squamous cell carcinoma of the esophagus and adenocarcinoma of gastroesophageal junction, a rare coincidence.
Iran Red Crescent Med J. 2011 Jul;13(7):507-9. Epub 2011 Jul 1.
3
Optical properties of adenocarcinoma and squamous cell carcinoma of the gastroesophageal junction.
J Biomed Opt. 2007 Jan-Feb;12(1):014025. doi: 10.1117/1.2564793.
4
The lack of association between adenocarcinoma of the esophagus and gastric surgery: a retrospective study.
Am J Gastroenterol. 1997 Feb;92(2):216-21.
5
Perioperative chemo(radio)therapy versus primary surgery for resectable adenocarcinoma of the stomach, gastroesophageal junction, and lower esophagus.
Cochrane Database Syst Rev. 2013 May 31;2013(5):CD008107. doi: 10.1002/14651858.CD008107.pub2.
6
[Adenocarcinoma of the esophagogastric junction: association with Barrett esophagus and gastroesophageal reflux--surgical results in 122 patients].
Leber Magen Darm. 1996 Mar;26(2):75-6, 79-80, 83-6.
7
Concepts in the prevention of adenocarcinoma of the distal esophagus and proximal stomach.
CA Cancer J Clin. 2005 Nov-Dec;55(6):334-51. doi: 10.3322/canjclin.55.6.334.
8
Epidemiological Review of Gastroesophageal Junction Adenocarcinoma in Asian Countries.
Digestion. 2022;103(1):29-36. doi: 10.1159/000519602. Epub 2021 Oct 29.
9
Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma.
Dig Dis Sci. 2000 Dec;45(12):2367-8. doi: 10.1023/a:1005638924929.
10
Cancer of the esophagus and stomach.
Mayo Clin Proc. 2008 Jun;83(6):712-22.
引用本文的文献
1
Deciphering the Controversial Role of TP53 Inducible Glycolysis and Apoptosis Regulator (TIGAR) in Cancer Metabolism as a Potential Therapeutic Strategy.
Cells. 2025 Apr 15;14(8):598. doi: 10.3390/cells14080598.
本文引用的文献
1
Dataset for the reporting of carcinoma of the esophagus in resection specimens: recommendations from the International Collaboration on Cancer Reporting.
Hum Pathol. 2021 Aug;114:54-65. doi: 10.1016/j.humpath.2021.05.003. Epub 2021 May 13.
2
Roles of long-non-coding RNAs in cancer therapy through the PI3K/Akt signalling pathway.
Histol Histopathol. 2019 Jun;34(6):593-609. doi: 10.14670/HH-18-081. Epub 2019 Jan 8.
Zotero 插件